Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53

Journal of Neuro-Oncology

Volumn 83, Issue 2, 2007, Pages 163-172

  Clark, Aaron J ^a,b   Chan, Dana C ^b   Chen, Mike Y ^a,b   Fillmore, Helen ^a,b   Dos Santos, Wagner G ^a   Van Meter, Timothy E ^a   Graf, Martin R ^a   Broaddus, William C ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Glioblastoma multiforme; P53; Radiotherapy; SiRNA; Wilms' tumor 1

Indexed keywords

PLASMID VECTOR; PROTEIN P53; SMALL INTERFERING RNA; WT1 PROTEIN;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANALYSIS OF VARIANCE; APOPTOSIS; BRAIN NEOPLASMS; DOWN-REGULATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; GLIOBLASTOMA; HUMANS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RADIATION TOLERANCE; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249026104     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9317-8     Document Type: Article

References (50)

1. CBTRUS (2006) Statistical report: Primary brain tumors in the United States, 1998-2002
2. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731
3. Simpson JR, Horton J, Scott C et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239-244
4. Walker MD, Alexander E Jr, Hunt WE et al (1978) Evaluation of BCNU and/ or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333-343
5. Haas-Kogan DA, Kogan SS, Yount G et al (1999) p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J Radiat Oncol Biol Phys 43:399-403
6. Chakravarti A, Dicker A, Mehta M (2004) The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data. Int J Radiat Oncol Biol Phys 58:927-931
7. Clark AJ, Dos Santos WG, McCready J et al (2007) Wilms' tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status. J Neurosurg (in press)
8. Menssen HD, Bertelmann E, Bartelt S et al (2000) Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens. J Cancer Res Clin Oncol 126:226-232
9. Dennis SL, Manji SSM, Carrington DP et al (2002) Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Int J Cancer 97:713-715
10. Nakahara Y, Okamoto H, Mineta T et al (2004) Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathol 21:113-116
11. Oji Y, Suzuki T, Nakano Y et al. (2004) Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors. Cancer Sci 95:822-827
12. Call KM, Glaser T, Ito CY et al (1990) Isolation and Characterization of A Zinc Finger Polypeptide Gene at the Human Chromosome-11 Wilms Tumor Locus. Cell 60:509-520
13. Haber DA, Sohn RL, Buckler AJ et al (1991) Alternative Splicing and Genomic Structure of the Wilms-Tumor Gene-Wt1. Proc Natl Acad Sci USA 88:9618-9622
14. Davies RC, Calvio C, Bratt E et al (1998) WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev 12:3217-3225
15. Hewitt SM, Fraizer GC, Wu YJ et al (1996) Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J Biol Chem 271:8588-8592
16. Richard DJ, Schumacher V, Royer-Pokora B et al (2001) Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1. Genes Dev 15:328-339
17. Inoue K, Sugiyama H, Ogawa H et al (1994) Wt1 As A New Prognostic Factor and A New Marker for the Detection of Minimal Residual Disease in Acute-Leukemia. Blood 84:3071-3079
18. Miyoshi Y, Ando A, Egawa C et al (2002) High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8:1167-1171
19. Svedberg H, Chylicki K, Baldetorp B et al (1998) Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 16:925-932
20. Zapata-Benavides P, Tuna M, Lopez-Berestein G et al (2002) Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295:784-790
21. Bogler O, Huang HJS, Kleihues P et al (1995) The P53 Gene and Its Role in Human Brain-Tumors. Glia 15:308-327
22. Vousden KH, Lu X (2002) Live or let die: The cell's response to p53. Nat Rev Cancer 2:594-604
23. Lowe SW, Ruley HE, Jacks T et al (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967
24. Barker FG, Simmons ML, Chang SM et al (2001) EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:410-418
25. Tada M, Matsumoto R, Iggo RD et al (1998) Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res 58:1793-1797
26. Alsner J, Sorensen SB, Overgaard J (2001) TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother Oncol 59:179-185
27. Yount GL, Haas-Kogan DA, Vidair CA et al (1996) Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 56:500-506
28. Broaddus WC, Liu Y, Steele LL et al (1999) Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction. J Neurosurg 91:997-1004
29. Badie B, Kramar MH, Lau R et al (1998) Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. J Neurooncol 37:217-222
30. Gjerset RA, Turla ST, Sobol RE et al (1995) Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53. Mol Carcinog 14:275-285
31. D'Avenia P, Porrello A, Berardo M et al (2006) Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: A strategy to convert a radio-resistant phenotype into a radiosensitive one. Cancer Lett 231:102-112
32. Schiebe M, Ohneseit P, Hoffmann W et al (2000) Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. J Neurooncol 49:197-203
33. Maheswaran S, Englert C, Bennett P et al (1995) The Wt1 Gene-Product Stabilizes P53 and Inhibits P53-Mediated Apoptosis. Genes Dev 9:2143-2156
34. Ishii N, Maier D, Merlo A et al (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469-479
35. Idelman G, Glaser T, Roberts CT et al (2003) WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation. J Biol Chem 278:3474-3482
36. Deb S, Jackson CT, Subler MA et al (1992) Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J Virol 66:6164-6170
37. Anker L, Ohgaki H, Ludeke BI et al (1993) p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer 55:982-987
38. Wang X, Ohnishi K, Takahashi A et al (1998) Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene 17:2819-2825
39. Englert C, Hou X, Maheswaran S et al (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675
40. Mayo MW, Wang CY, Drouin SS et al (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 18:3990-4003
41. Englert C, Maheswaran S, Garvin AJ et al (1997) Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57:1429-1434
42. Crighton D, Wilkinson S, O'Prey J et al (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121-134
43. Ito K, Oji Y, Tatsumi N et al (2006) Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene 25:4217-4229
44. Liu XW, Gong LJ, Guo LY et al (2001) The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J Biol Chem 276:5068-5073
45. Wang ZY, Qiu QQ, Deuel TF (1993) The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem 268:9172-9175
46. Holdhoff M, Kreuzer KA, Appelt C et al (2005) Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Blood Cells Mol Dis 34:181-185
47. Scharnhorst V, van der Eb AJ, Jochemsen AG (2001) WT1 proteins: functions in growth and differentiation. Gene 273:141-161
48. Scharnhorst V, Dekker P, van der Eb AJ et al (2000) Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. J Biol Chem 275:10202-10211
49. Yuan ZM, Shioya H, Ishiko T et al (1999) p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399:814-817
50. Sasaki Y, Morimoto I, Ishida S et al (2001) Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: Potential application to gene therapy of colorectal cancer. Gene Ther 8:1401-1408